Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8078K)
June 27 2014 - 11:07AM
UK Regulatory
TIDMHIK
RNS Number : 8078K
Hikma Pharmaceuticals Plc
27 June 2014
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters
State whether the notification
relates to (i) a transaction
notified in accordance with
DTR 3.1.2 R, (ii) a disclosure
made in accordance with
LR 9.8.6R(1) or (iii) a
disclosure made in accordance
with section 793 of the
Name of the Issuer: Companies Act (2006):
1. Hikma Pharmaceuticals PLC 2. DTR 3.1.2 R
---- --------------------------------------- ---- -----------------------------------
State whether notification
relates to a person connected
with a person discharging
managerial responsibilities/
director named in 3 and
identify the connected person:
Nisreen Z. Sh. Oun Alsharifeh
(wife)
Tala M. A. KH. Al-Husry
Name of person discharging (daughter)
managerial responsibilities/director: Haya M.A. KH. Al-Husry (daughter)
Mohammed Ali Khaldoun S Faisal Sate M. A. KH. Al
3. Al-Husry 4. Husry (son)
---- --------------------------------------- ---- -----------------------------------
Indicate whether the notification Description of shares (including
is in respect of a holding class), debentures or derivatives
of the person referred to or financial instruments
in 3 or 4 above or in respect relating to shares:
of a non-beneficial interest: Ordinary Shares in Hikma
All persons in 3 and 4 and Ordinary Shares in Darhold
their shareholdings in Hikma Limited, the holding vehicle
5. (whether direct or indirect) 6. for shares in Hikma
---- --------------------------------------- ---- -----------------------------------
Name of registered shareholders(s) State the nature of the
and, if more than one, the transaction:
number of shares held by Encumbrance in support of
each of them: a loan of the shareholdings
DYKB Limited, a British in Hikma and Darhold belonging
Virgin Islands company which to DKYB Limited, on behalf
is acting as a holding company of the persons noted in
7. for the Al-Husry family. 8. 3 and 4, above.
---- --------------------------------------- ---- -----------------------------------
Percentage of issued class
acquired (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares acquired: calculating percentage):
9. None 10. N/A
---- --------------------------------------- ---- -----------------------------------
Percentage of issued class
disposed (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares disposed: calculating percentage):
11. None 12. N/A
---- --------------------------------------- ---- -----------------------------------
Price per share or value
of transaction: Date and place of transaction:
13. N/A 14. London, 27 June 2014
---- --------------------------------------- ---- -----------------------------------
Total holding following
notification and total percentage
holding following notification
(any treasury shares should
not be taken into account
when calculating percentage):
5,109,748 (2.61%) shares
in Hikma comprising:
Directly: 1,109,748 (0.59%) Date issuer informed of
Indirectly through Darhold transaction:
15. limited: 4,000,000 (2.02%) 16. 27 June 2014
---- --------------------------------------- ---- -----------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer complete the following boxes
------------------------------------------------------------------------------
Period during which or date
17. Date of grant 18. on which exercisable
---- --------------------------------- ---- -------------------------------
Total amount paid (if Description of shares or
any) for grant of the debentures involved (class
19. option 20. and number)
---- --------------------------------- ---- -------------------------------
Exercise price (if fixed
at time of grant) or indication Total number of shares or
that price is to be fixed debentures over which options
21. at the time of exercise 22. held following notification
---- --------------------------------- ---- -------------------------------
Name of contact and telephone
23. Any additional information 24. number for queries
---- --------------------------------- ---- -------------------------------
Name of authorised official or issuer responsible for making
notification
Peter Speirs, Company Secretary, Hikma Pharmaceuticals PLC
Date of notification: 27 June 2014
-------------------------------------------------------------
Notes:
This form is intended for use by an issuer to make a RIS
notification required by DTR 3.1.4
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6,
8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options
granted to a director/person discharging managerial
responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a
debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16,
23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBUGDLGGDBGSR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024